Drug Targets for Ebola, Dengue, and Zika Viruses Found in Lab Study
Scientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
University of California San Francisco
Give to UCSFScientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
Thirty-five years after its launch, Ward 86 continues to be a global leader in HIV care and has significantly influenced milestones in treatment and prevention.
UC San Francisco, National Jewish Health and Centro de Neumología Pediátrica in Puerto Rico have been awarded nearly $10 million to address the root causes of asthma in children in Puerto Rico.
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend.
These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.
A group of researchers from the Gladstone Institutes, UCSF, and UC Berkeley used a systematic approach to get an entirely new look at the way tuberculosis infects people.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
Mayor Mark Farrell announced $4.2 million in additional funds for HIV/AIDS programs in San Francisco.
Infectious disease expert Charles Chiu explains the rise in Lyme disease cases, better diagnostic tests on the horizon and what you need to know to protect yourself from infection.
More than 100 members of the malaria research community in the Bay Area gathered to celebrate World Malaria Day on April 25 at Zuckerberg San Francisco General Hospital.
Treating young children in Sub-Saharan Africa with azithromycin, a safe, inexpensive, and widely used antibiotic, significantly reduced deaths of children under five.